Skip to content
i2E
  • Programs
    • E3
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
Menu
  • Programs
    • E3
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
Search

Oklahoma Blood Institute adds research initiative

Get in Touch

By Jim Stafford

Copyright © 2014, The Oklahoma Publishing Company

Adult stem cells are the lifeblood of groundbreaking scientific developments in which researchers can take a stem cell and use it to grow skin or a tendon or an ear.

It’s called regenerative medicine. Amazing stuff.

For scientists involved in advances in regenerative medicine, their discipline begins with access to adult stem cells.

The use of adult stem cells has largely reduced the criticism of stem cell research because it replaces the controversial study of fetal stem cells.

But where do scientists obtain adult stem cells?

Charles Mooney
Charles Mooney

The answer for scientists in Oklahoma and beyond may be found at the Oklahoma Blood Institute (OBI) and a new initiative it’s launching called BioShare.

Through BioShare, OBI will supply researchers with stem cells and other blood products, said Charles Mooney, the blood bank’s vice president of New Ventures & Quality Management.

“The community blood bank is the entity with the most expertise to facilitate the collection of cells needed to develop these new cell therapies,” Mooney told me during a recent visit in his office at OBI’s headquarters, at 901 N Lincoln on the Oklahoma Health Center campus.

OBI collects approximately 250,000 blood donations annually, which includes whole blood donations as well as plasma, platelets and other blood products.

Since blood products have a limited shelf life, sometimes a hospital doesn’t use its supply before expiration, so the blood supply is refreshed. BioShare creates new uses for unused blood products.

“We’ve got stem cells, red blood cells, white blood cells, we’ve got platelets, we’ve got plasma, we’ve got serum, and we can collect other things that people need us to collect,” Mooney said.

BioShare is one of three initiatives OBI is launching.

BioLinked is a second initiative, under which the institute will create a database of people who agree to participate in future research studies.

The third initiative is BioCareNextion, through which OBI can connect blood donors to health care providers when it discovers a health problem during the screening or collection process.

State’s biotech leader

OBI is already big. It provides blood products to 158 hospitals across Oklahoma and into both Texas and Arkansas.

It employs 765 health care professionals who collect blood, process it under very strict FDA guidelines and service hospitals from Woodward in the west to Pine Bluff, Ark., in the east and south to Vernon, Texas.

“OBI is the largest bio company in Oklahoma,” Mooney said. “Often, people don’t think of OBI when they think of biotech. We are about as biotech as you can be.”

So, why expand beyond the business of collecting blood and supplying it to hospitals?

“It costs a whole lot of money to get that blood from a donor’s arm into a patient,” Mooney said. “It’s not just draw it and hand it to the hospital. It is regulated by the FDA like a prescription drug. It’s a very expensive undertaking and takes a whole lot of business and science talent to pull it off.”

Still, OBI’s mission remains unchanged.

“All of this OBI wants to do so that we can fulfill our not-for-profit mission, which is that we provide the community with the blood and other cells that the community is going to need both now and in the future,” Mooney said.

And that’s the real bottom line.

Read the article at newsok.com

 

 

 

Author

  • admin admin

More News

Loading...
woman in lab conducting a study
Blog, i2E
12.13.22

Bayesic Technologies Improves Effectiveness and Efficiency of Data Analysis in Healthcare

Read more
Bison grazing fields
Blog
11.30.22

Bison Underground Merges Nature, Science, and Technology to Tackle Climate Change

Read more
African American family sitting on couch reading and chatting
Blog, E3, i2E
11.22.22

Fokes Connects Families, Caregivers and Care Agencies for Smoother Communications and Care 

Read more
i2e blog post graphic
Blog, News
11.03.22

Introducing: Stories of Oklahoma Innovation

Read more
Default Featured Image
OKBio
06.28.22

Oklahoma Grown! i2E Invests in BIO startups

Read more
Default Featured Image
OKBio
06.13.22

Oklahoma Medical Research Foundation BIO

Read more
Default Featured Image
OKBio
06.13.22

Moleculera Labs BIO

Read more
Default Featured Image
OKBio
06.13.22

University of Oklahoma Health Sciences Center BIO

Read more
Default Featured Image
OKBio
06.13.22

Oklahoma State University BIO

Read more
Default Featured Image
OKBio
06.13.22

ECHO Investment Capital BIO

Read more
Default Featured Image
OKBio
06.13.22

AscendBioVentures BIO

Read more
Default Featured Image
OKBio
06.13.22

Dean McGee Eye Institute BIO

Read more
i2E

Oklahoma City Office

840 Research Parkway, Suite 250
OKC, OK 73104
+1 (405) 235.2305

Tulsa Office

100 S. Cincinnati Ave – Suite 514
Tulsa, OK 74103
+1 (918) 582.5592

  • Client Portfolio
  • About Us
  • Media
  • Events
  • Contact
  • Resources

© 2022 i2E Privacy Policy

Follow us:

Facebook Twitter Linkedin

Programs

  • E3
  • ACT Tulsa
  • Love's Entrepreneur's Cup
  • OKBio
  • Client Portfolio

Services

  • Access to Funding
  • Venture Advisory Services
  • Contact
  • About
  • Our Values
  • Our Team
  • Board of Directors
  • Corporate Partners
  • Media
i2E